Abstract
The surgical approach (midfacial degloving, lateral rhinotomy, craniofacial, or endoscopic), can complicate the radiation fi eld.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
General Principles of Target Delineation
-
The surgical approach (midfacial degloving, lateral rhinotomy, craniofacial, or endoscopic), can complicate the radiation field. If a craniofacial resection has been performed, the frontal graft should be included in the target volume. Fiducial markers implanted during surgery can help to delineate the tumor bed.
-
Preoperative CT and MRI should be evaluated to ensure that the initial tumor volume is covered in the high-risk CTV. Detailed description of the surgical procedure and pathology report is mandatory to properly define the CTV that should encompass all initial sites of disease and the subclinical tumor spread. MRI should be used in all cases to help delineation of the tumor unless medically contraindicated.
-
Adenoid cystic carcinomas are highly neurotrophic so radiotherapy volumes must encompass the afferent and efferent local nerves to the skull base. Esthesioneuroblastomas arise in the superior nasal cavity and in their early stages tend to invade the cribriform plate and anterior cranial fossa, and therefore, these regions should be encompassed in the target volume.
-
Lymph node metastases are unusual, so elective treatment of the neck is not mandatory but can be done at the discretion of the treating physician. However, elective neck irradiation should be considered for esthesioneuroblastoma; high-grade, high-stage squamous cell carcinoma, especially if originating from the maxillary sinus or there is invasion of the mucosa of the palate or of the nasopharynx; when there is involvement of the skin of the cheek or of the anterior nose; and invasion of the maxillary gingiva or the alveolus. Depending on the clinical situation (if tumor is well lateralized or if it crosses the midline), the lymph node levels Ib-IV can be covered (either unilaterally or bilaterally based on the clinical scenario).
-
Suggested target volumes at the gross disease and high- and low-risk regions are detailed in Tables 6.1 and 6.2 (Figs. 6.1 and 6.2).
Further Reading
Bristol IJ, Ahamad A, Garden AS et al (2007) Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys 68:719–730
Chen AM, Daly ME, Bucci MK et al (2007) Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys 69:141–147
Le QT, Fu KK, Kaplan MJ et al (2000) Lymph node metastasis in maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 46:541–549
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Spratt, D., Cabanillas, R., Lee, N.Y. (2013). The Paranasal Sinuses. In: Lee, N., Lu, J. (eds) Target Volume Delineation and Field Setup. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28860-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-28860-9_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28859-3
Online ISBN: 978-3-642-28860-9
eBook Packages: MedicineMedicine (R0)